Use of a male antioxidant nutraceutical is associated with superior live birth rates during IVF treatment.

We acknowledge some differences in patient characteristics between the two primary comparator groups, with significantly more male factor infertility in the Menevit group, while endometriosis and ovulatory dysfunction were slightly more common in the controls, although the latter did not reach statistical significance.

also in 111,027 other papers